Psy57 - A Comparison Between on Demand Usage of Rfviia vs Prophylaxis Use of Emicizumab in High Titer Inhibitory Hemophilia a Patients in Iran; A Cost Utility Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2633
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness Analysis of Prophylaxis vs On-Demand Supply of Factor Ix in Patients Diagnosed With Moderate Hemophilia B in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

A Randomized Comparison of Two Prophylaxis Regimens and a Paired Comparison of On-Demand and Prophylaxis Treatments in Hemophilia a Management

Journal of Thrombosis and Haemostasis
MedicineHematology
2012English

Malaria Treatment vs. Malaria Prophylaxis : A Cost Comparison.

Zagazig University Medical Journal
2014English

Psy95 - Exploring the Potential Cost-Effectiveness of Emicizumab for Hemophilia a With Inhibitor in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Efficacy of Emicizumab Prophylaxis Versus Factor VIII Prophylaxis for Treatment of Hemophilia a Without Inhibitors: Network Meta-Analysis and Subgroup Analyses of the Intra-Patient Comparison of the HAVEN 3 Trial

Current Medical Research and Opinion
Medicine
2019English

Pertussis Post-Exposure Prophylaxis Among Household Contacts: A Cost-Utility Analysis

PLoS ONE
Multidisciplinary
2015English

Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared to Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Successful Use of Emicizumab in a Patient With Refractory Acquired Hemophilia a and Acute Coronary Syndrome Requiring Percutaneous Coronary Intervention

Research and Practice in Thrombosis and Haemostasis
2019English

Major Surgery Management in Patients With Haemophilia a and Inhibitors on Emicizumab Prophylaxis Without Global Coagulation Monitoring

British Journal of Haematology
Hematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy